The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
Celebrities are turning to weight loss medications like Ozempic and Mounjaro to stay in shape, sparking a conversation about ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
It’s been over three decades since actress Bridget Fonda’s lead role in “Single White Female.” She starred in several films ...
Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...
The Growing Market for Weight Loss Treatments: Innovation, Patents, and the Future of GLP-1 Agonists
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
If you've been scrolling through TikTok recently, you might have come across the "winter arc" trend — a sort of fresh take on ...
Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.
Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback